The global spread of COVID-19 has impacted all aspects of business and raises significant securities law questions for public life sciences companies. In this video, Fenwick partners Rob Freedman and Amanda Rose discuss the securities law considerations that should be top of mind.
View the video and the slide deck for this webinar.
Topics covered include:
- SEC Updates
- Governance Considerations
- IR/PR Considerations
- Periodic Reporting Considerations
- Financing Considerations
You can access additional webinars, videos, alerts and articles at Fenwick’s COVID-19 Resource Center.